| Anvita Sinha, MD | |
|
600 Coffee Rd, Modesto, CA 95355-4201 | |
| (209) 521-6097 | |
| Not Available |
| Full Name | Anvita Sinha |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Location | 600 Coffee Rd, Modesto, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467463422 | NPI | - | NPPES |
| 23D0366233 | Other | MI | CLIA |
| 3408217790 | Other | MI | BLUECROSSBLUESHIELD MI |
| 200907330 | Medicaid | IN | |
| 3193742 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | AS056566 (Michigan) | Secondary |
| 208800000X | Urology | 01065467A (Indiana) | Secondary |
| 208800000X | Urology | G144001 (California) | Primary |
| Entity Name | Lutheran Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164662805 PECOS PAC ID: 4981751617 Enrollment ID: O20090414000705 |
News Archive
PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.
Researchers at Benaroya Research Institute at Virginia Mason used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA). "By using tetramer technology, we were able to examine whether T cells in people with rheumatoid arthritis were increased in number or were unique in other ways," says BRI Associate Director Jane Buckner, MD, who led the study with BRI Tetramer Core Laboratory Manager Eddie James, PhD.
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In my column on Sunday, I quoted Mitt Romney's warning last week that President Obama's health reform law could doom the free-enterprise system in the United States. "With Obamacare fully installed," Romney said, "government will come to control half the economy, and we will have effectively ceased to be a free-enterprise society." Could that be true? Would "Obamacare," which relies mostly on free-enterprise health insurance companies, really turn America into a socialist state?
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anvita Sinha, MD 600 Coffee Rd, Modesto, CA 95355-4201 Ph: (209) 521-6097 | Anvita Sinha, MD 600 Coffee Rd, Modesto, CA 95355-4201 Ph: (209) 521-6097 |
News Archive
PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech's milk-derived exosome platform technology for the oral administration of Roche's antisense oligonucleotide platform.
Researchers at Benaroya Research Institute at Virginia Mason used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA). "By using tetramer technology, we were able to examine whether T cells in people with rheumatoid arthritis were increased in number or were unique in other ways," says BRI Associate Director Jane Buckner, MD, who led the study with BRI Tetramer Core Laboratory Manager Eddie James, PhD.
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In my column on Sunday, I quoted Mitt Romney's warning last week that President Obama's health reform law could doom the free-enterprise system in the United States. "With Obamacare fully installed," Romney said, "government will come to control half the economy, and we will have effectively ceased to be a free-enterprise society." Could that be true? Would "Obamacare," which relies mostly on free-enterprise health insurance companies, really turn America into a socialist state?
› Verified 9 days ago
Mr. Brian T Mc Caffrey, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388 Fax: 209-523-0764 | |
Walter J Schimon, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-524-1211 | |
Preetinder K. Brar, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-557-1000 | |
Steven R Wunschel, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Spanos Ct, 111, Modesto, CA 95355 Phone: 209-525-3181 Fax: 209-526-4961 | |
Mr. Phillip H Beck, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388 Fax: 209-523-0764 | |
Curtis Richard Dewar, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388 Fax: 209-523-0764 |